{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:10:49Z","timestamp":1782461449782,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1SC1HL154511-01"],"award-info":[{"award-number":["1SC1HL154511-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1927628"],"award-info":[{"award-number":["1927628"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1R21NS121945"],"award-info":[{"award-number":["1R21NS121945"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.bbrc.2023.01.014","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T01:55:25Z","timestamp":1673056525000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Inhibition of ERK 1\/2 pathway downregulates YAP1\/TAZ signaling in human cardiomyocytes exposed to hyperglycemic conditions"],"prefix":"10.1016","volume":"648","author":[{"given":"Binata","family":"Joddar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla D.","family":"Loyola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma P.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-3140","authenticated-orcid":false,"given":"Abhinaya","family":"Muruganandham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irtisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbrc.2023.01.014_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2023.01.014_bib2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.biopha.2018.11.086","article-title":"Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate","volume":"109","author":"Al Hroob","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2023.01.014_bib3","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control","volume":"9","author":"Borghetti","year":"2018","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.bbrc.2023.01.014_bib4","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2337\/db08-0617","article-title":"Rac1 is required for cardiomyocyte apoptosis during hyperglycemia","volume":"58","author":"Shen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2023.01.014_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fcvm.2020.00012","article-title":"Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy","volume":"7","author":"Kaludercic","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.bbrc.2023.01.014_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","article-title":"Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy","volume":"90","author":"Ni","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.bbrc.2023.01.014_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.bbrc.2023.01.014_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/FJC.0000000000000736","article-title":"Role of YAP\/TAZ in energy metabolism in the heart","volume":"74","author":"Kashihara","year":"2019","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"issue":"17","key":"10.1016\/j.bbrc.2023.01.014_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl9404","article-title":"Dissociation of nanosilicates induces downstream endochondral differentiation gene expression program","volume":"8","author":"Brokesh","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2023.01.014_bib10","doi-asserted-by":"crossref","DOI":"10.34133\/2021\/9864212","article-title":"3D bioprinted spheroidal droplets for engineering the heterocellular coupling between cardiomyocytes and cardiac fibroblasts","volume":"2021","author":"El Khoury","year":"2021","journal-title":"Cyborg and Bionic Systems"},{"issue":"9","key":"10.1016\/j.bbrc.2023.01.014_bib11","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1039\/C8SC00043C","article-title":"Isoform-selective activity-based profiling of ERK signaling","volume":"9","author":"Shin","year":"2018","journal-title":"Chem. Sci."},{"issue":"7","key":"10.1016\/j.bbrc.2023.01.014_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.bbrc.2023.01.014_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.devcel.2013.01.020","article-title":"Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins","volume":"24","author":"Reddy","year":"2013","journal-title":"Dev. Cell"},{"issue":"6","key":"10.1016\/j.bbrc.2023.01.014_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039066","article-title":"Activation of EGFR\/ERBB2 via pathways involving ERK1\/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury","volume":"7","author":"Akhtar","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbrc.2023.01.014_bib15","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.00206.2015","article-title":"Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways","volume":"310","author":"Mapanga","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"19","key":"10.1016\/j.bbrc.2023.01.014_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910802","article-title":"Changes in stress-mediated markers in a human cardiomyocyte cell line under hyperglycemia","volume":"22","author":"Thakur","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbrc.2023.01.014_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.5603\/CJ.a2018.0113","article-title":"Identification of biomarkers and mechanisms of diabetic cardiomyopathy using microarray data","volume":"27","author":"Li","year":"2020","journal-title":"Cardiol. J."},{"issue":"9","key":"10.1016\/j.bbrc.2023.01.014_bib18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.cardfail.2007.06.730","article-title":"Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy","volume":"13","author":"Ohtsuka","year":"2007","journal-title":"J.\u00a0Card. Fail."},{"issue":"1","key":"10.1016\/j.bbrc.2023.01.014_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2014.12.024","article-title":"The varying faces of IL-6: from cardiac protection to cardiac failure","volume":"74","author":"Fontes","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.bbrc.2023.01.014_bib20","article-title":"The CXCL10\/CXCR3 Axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart","volume":"2016","author":"Altara","year":"2016","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.bbrc.2023.01.014_bib21","article-title":"Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bbrc.2023.01.014_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yexmp.2017.11.006","article-title":"Activation of Yap1\/Taz signaling in ischemic heart disease and dilated cardiomyopathy","volume":"103","author":"Hou","year":"2017","journal-title":"Exp. Mol. Pathol."},{"issue":"6","key":"10.1016\/j.bbrc.2023.01.014_bib23","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.18632\/oncotarget.2974","article-title":"Inhibition of ERK1\/2 down-regulates the Hippo\/YAP signaling pathway in human NSCLC cells","volume":"6","author":"You","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2023.01.014_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fcell.2019.00211","article-title":"The Hippo signaling pathway in cardiac development and diseases","volume":"7","author":"Mia","year":"2019","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:04:29Z","timestamp":1777399469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"alternative-id":["S0006291X23000268"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.014","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of ERK 1\/2 pathway downregulates YAP1\/TAZ signaling in human cardiomyocytes exposed to hyperglycemic conditions","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}